The New WHO Classification of Lung Tumors

Lung Cancer Biomarker Testing Patterns Varied Widely in Japan

Patient Comment on Mobocertinib for Exon 20

Trastuzumab Deruxtecan Potential New Treatment Options for HER2+ NSCLC

Targeting KRAS in Lung Cancer: The Past, Present, and Future 

Mobocertinib May Offer Effective, Safe Treatment in NSCLC with EGFR Exon 20 Insertion Mutation

Program Covers Broad Spectrum of Topics in Thoracic Oncology

Make the Most of WCLC 2023: Mobile App Launches August 31

Know Before You Go: Getting To—And Around—Singapore

Order Tickets for Special Events Today

See you in Singapore for the 2023 World Conference on Lung Cancer

2023 IASLC Academy to Compete in Amazing Case Race